| Immunobiology and immunotherapy of COVID‐19: A clinically updated overview A Esmaeilzadeh, R Elahi Journal of Cellular Physiology, 2020 | 91 | 2020 |
| Solid tumors challenges and new insights of CAR T cell engineering S Tahmasebi, R Elahi, A Esmaeilzadeh Stem cell reviews and reports 15, 619-636, 2019 | 90 | 2019 |
| Immune cell hacking: challenges and clinical approaches to create smarter generations of chimeric antigen receptor T cells R Elahi, E Khosh, S Tahmasebi, A Esmaeilzadeh Frontiers in immunology 9, 1717, 2018 | 76 | 2018 |
| Chimeric antigen receptor-engineered natural killer (CAR NK) cells in cancer treatment; recent advances and future prospects R Elahi, AH Heidary, K Hadiloo, A Esmaeilzadeh Stem Cell Reviews and Reports 17, 2081-2106, 2021 | 53 | 2021 |
| OMICRON: Virology, immunopathogenesis, and laboratory diagnosis M Bazargan, R Elahi, A Esmaeilzadeh The Journal of Gene Medicine 24 (7), e3435, 2022 | 48 | 2022 |
| An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19) R Elahi, P Karami, AH Heidary, A Esmaeilzadeh International immunopharmacology 105, 108536, 2022 | 39 | 2022 |
| Programmable and multi‑targeted CARs: a new breakthrough in cancer CAR‑T cell therapy S Tahmasebi, R Elahi, E Khosh, A Esmaeilzadeh Clinical and translational oncology, 2020 | 39 | 2020 |
| Immune-based therapy for COVID-19 A Esmaeilzadeh, D Jafari, S Tahmasebi, R Elahi, E Khosh Coronavirus Disease-COVID-19, 449-468, 2021 | 22 | 2021 |
| IL-38 as an early predictor of the ischemic stroke prognosis MZ Rafie, A Esmaeilzadeh, A Ghoreishi, S Tahmasebi, E Faghihzadeh, ... Cytokine 146, 155626, 2021 | 20 | 2021 |
| Endocrine and metabolic complications of COVID-19: lessons learned and future prospects A Esmaeilzadeh, R Elahi, A Siahmansouri, AJ Maleki, A Moradi Journal of Molecular Endocrinology 69 (3), R125-R150, 2022 | 15 | 2022 |
| Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks A Esmaeilzadeh, AJ Maleki, A Moradi, A Siahmansouri, MJ Yavari, ... Expert Review of Vaccines 21 (10), 1377-1394, 2022 | 14 | 2022 |
| Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors A Esmaeilzadeh, K Hadiloo, M Jabbari, R Elahi Life Sciences, 122381, 2023 | 7 | 2023 |
| Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches S Ahmadi, M Bazargan, R Elahi, A Esmaeilzadeh Molecular Immunology 156, 10-19, 2023 | 7 | 2023 |
| The role of heat shock proteins (HSPs) in type 2 diabetes mellitus pathophysiology A Esmaeilzadeh, V Mohammadi, R Elahi, N Rezakhani Journal of Diabetes and its Complications, 108564, 2023 | 5 | 2023 |
| Clinical applications of interleukin-37; as a key player in the immunopathogenesis of immune disorders E Khosh, N Bahmaie, R Elahi, A Esmaeilzadeh Iranian Journal of Allergy, Asthma and Immunology, 2020 | 5 | 2020 |
| Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19) R Elahi, S Hozhabri, A Moradi, A Siahmansouri, A Jahani Maleki, ... Immunopharmacology and Immunotoxicology 45 (6), 639-649, 2023 | 4 | 2023 |
| Transforming growth factor β (TGF-β) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches A Esmaeilzadeh, V Mohammadi, R Elahi Molecular Biology Reports 50 (7), 6121-6131, 2023 | 4 | 2023 |
| Benign Cerebral Edema and Increased Intracranial Pressure (ICP) as manifestations of COVID-19 reinfection; A case report A Heidary, R Elahi, M Nazari J Clin Lab Med 6 (1), 138, 2021 | 4 | 2021 |
| Chimeric antigen receptor (CAR)-based cell therapy for type 1 diabetes mellitus (T1DM); current Progress and future approaches V Mohammadi, AJ Maleki, M Nazari, A Siahmansouri, A Moradi, R Elahi, ... Stem Cell Reviews and Reports 20 (3), 585-600, 2024 | 3 | 2024 |
| IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches R Elahi, M Nazari, V Mohammadi, K Esmaeilzadeh, A Esmaeilzadeh | 2 | 2023 |
Abdolreza EsmaeilzadehProfessor of Medical Immunology, Immunology Dept and Cancer Gene Therapy Research Center, School of在 zums.ac.ir 的电子邮件经过验证
